Abstract
Beta-cell replacement, by either pancreas or islet transplantation, is the only treatment to achieve an insulin-independent, constantly normoglycemic state avoiding hypoglycemic episodes in patients with type-1 diabetes mellitus. This article reviews the current state of the worldwide experience based on data provided by the International Islet Transplant Registry; it also illustrates the perspectives of clinical islet transplantation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: February 7, 2000 / Accepted: February 29, 2000
About this article
Cite this article
Bretzel, R. Current status and perspectives in clinical islet transplantation. J Hep Bil Pancr Surg 7, 370–373 (2000). https://doi.org/10.1007/s005340070031
Issue Date:
DOI: https://doi.org/10.1007/s005340070031